ARTICLE | Clinical News
APN201: Phase Ib started
March 5, 2012 8:00 AM UTC
Apeiron began a double-blind, placebo-controlled, Austrian Phase Ib trial to evaluate APN201 given prior to radiation therapy in about 20 patients. Apeiron has exclusive, worldwide rights to develop r...